CORRECTIVE EFFECT OF THIOTRIAZOLINE ON TOXICITY AND CONDITION OF PRO- AND ANTIOXIDANT HOMEOSTASIS IN RATS AGAINST TOXIC ACTION OF NANOCHROMIUM CITRATE
DOI:
https://doi.org/10.11603/2312-0967.2017.1.7524Keywords:
nanochromium citrate, toxicity, pro- and antioxidant homeostasis, thiotriazoline.Abstract
The aim of the study. Researching a corrective effect of thiotriazoline on general toxicity and parameters of biochemical detoxication under conditions of action of nanochromium citrate toxic doses.
Materials and Methods. The effect of thiotriazoline (100 mg/kg) on nanochromium citrate (NCC) toxicity and condition of pro- and antioxidant homeostasis against a single injection of sublethal (DL0) and lethal (DL50, DL100) doses of the compound (3 mg/kg, 4,5 mg/kg, 5 mg/kg) is examined in an acute experiment on laboratory rats. The content of Malone aldehyde (MA), reduced glutathione (Г-SH) and catalase activity (CA) was detected in the erythrocytes. General antioxidant activity (GAA), the content of oxidizing-modied proteins (OMP) and free SH-groups were detected in the blood plasma. The content of MA, Г-SH, OMP and CA was studied in the post-nuclear supernatants of the liver homogenates.
Results and Discussion. Administration of thiotriazoline with therapeutic purpose against sublethal and lethal doses of NCC is found to decrease considerably the signs of intoxication and increase survival of animals. Since untreated animals died on the 2-3 days, under thiotriazoline action it occurred on the 6-8 days. Intoxication of animals with high doses of NCC is accompanied by intensication of the processes of free radical lipid oxidation and protein oxidation modication in the body, reduced activity of catalase, general antioxidant activity of the blood plasma, content of free SH-groups and reduced glutathione. The action of thiotriazoline against minimally toxic dose of NCC (3 mg/kg) appeared to be more effective as compared to untreated animals antioxidant activity in the blood plasma increased reliably without noticeable changes of SH-groups content.
Conclusions. A prolonged administration of thiotriazoline decreased the signs of intoxication and lethal outcome of animals against toxic doses of nanochromium citrate in an acute experiment. Thiotriazoline prevents the development of disorders of oxidizing-antioxidizing homeostasis in the body of intoxicated animals, although, a single injection of thiotriazoline against lethal doses of nanochromium citrate is less effective.
References
Bibik EYu, Fomina KA, Yushchak MV. [Thiotriazoline – potential drug with detoxication activity]. Ukr med alm. 2009; 1(12): 213-7. Ukrainian.
Verevkina IV, Tochilkin AI, Popova NA. Modern methods in biochemistry. [Современные методы в биохимии] Moskva: Meditsina; 1977. Russian.
Stefanova OV. Preclinical studies of drugs (guidelines). [Доклінічні дослідження лікарських засобів (методичні рекомендації)] Kyiv: Avicena; 2001. Ukrainian.
Iskra RYa. Biokhimichni protsesy v orhanizmi tvaryn za dii riznykh spoluk khromu (III). [Біохімічні процеси в організмі тварин за дії різних сполук хрому (ІІІ)] Thesis. Dis. Dr. biol. Sciences: 03.00.04: Lviv; 2013. Ukrainian.
Kopchuk TG. [Pharmacological effects Thiotriazoline]. Sovremen nauch Vestnik 2014; 10 (206): 66-1. Ukrainian.
Chekman IS, Gorchakova NA, Frantsuzova SB, Mintser VO, Svintsitskiy AS. Metabolite and metabolitotropnye drugs in cardio system and organ protection. [Метаболитные и метаболитотропные препараты в системе кардио- и органопротекции] Kyiv; 2009. Ukrainian.
Korolyuk MA, Ivanova LI, Mayorova IG, Tokareva VE. [The method for determining the activity of catalase]. Lab delo. 1998; 1:16-18. Russian.
Byelenichev IF, Mazur IA, Voloshyn MA, Gorchakova NO, Chekman IS. [The mechanism of energotropic and antioxidant action of Thiotriazoline]. Nov med i farm 2008; 13-14: 249-50. Ukrainian.
Meshhyshen IF. [The method of determining the oxidation-modied plasma proteins (serum) blood]. Buk med visnyk. 1998; 1(2): 156-58.
Avtsyn AP, Zhavoronkov AA, Rish MA, Strochkova LS. Microelementoses person. [Микроэлементозы человека] Moskva: Meditsina; 1991. Russian.
Chekman IS, Ulber ZR, Malanchuk VO, Gorchakova NO, Zupanecz IA. Nanosciences, Nanobiology, Nanopharma-ceutics. [Нанонаука, нанобіологія, нанофармація] Kyiv: Poligraf plyus; 2012. Ukrainian.
Bandas IA, Krynyczka IYa, Kuliczka MI, Korda MM. [Nanoparticles: the importance of today, the classication used in medicine, toxicity]. Med ta klin khimiya. 2015; 3 (17): 123-8. Ukrainian.
Gordiyenko VV, Kosuba RB, inventors; Bukovyna State Medical University, assignee. Application Thiotriazoline as detoxicant intoxication with salts of heavy metals. UA 15770 (Patent) 2006 Jan 20. Ukrainian.
Kosinov MV, Kaplunenko VG, inventors; Ltd. «Nano-materials and Nanotechnologies», assignee. Method akvahelativ nanometaliv «Erosion-explosive nanotechnology receiving akvahelativ nanometaliv». UA 29856 (Patent) 2008 Jan 25. Ukrainian.
Gerush OV, Kosuba RB, Pinyazhko OR, Gordiyenko VV, Gerush IV. Renal effects of Thiotriazoline: guidelines [Ренальні ефекти тіотриазоліну: методичні рекомендації] Kyiv; 2003. Ukrainian.
Sadogurska KV. [The study of acute toxicity nanochrom citrate under different routes of administration]. Farmacevt chasop. 2015; 4 (36): 56-9. Ukrainian.
Stal’naya ID, Garishvili TG. Methods of determining malonic dialdehyde using thiobarbituric acid [Методы определения малонового диальдегида с помощью тиобарбитуровой кислоты] Moskva: Meditsina; 1977. Russian.
Yaremij IM, Grygoryeva NP, Meshhyshen IF. [The inuence of mountain arnica tincture on the state of lipid peroxidation and protective systems hlutationovoyi liver of rats under the experimental toxic hepatitis]. Ukr bioxim zhurn. 1998; 70: 78-2. Ukrainian.
Cefalu WT.[Role of Chromium in Human Health and in Diabetes] Diabetes Care. 2004; 14 (27): 2741-51.
Lushchak OV, Kubrak OІ, Torous IM, Nazarchuk TV, Storey KB, Lushchak VІ. [Trivalent chromium induces oxidative stress in goldsh brain] Chemosphere. 2009; 75: 56-2.
Zha LY, Xu ZR, Wang MQ, Gu LY. [Effects of chromium nanoparticle dosage on growth, body composition, serum hormones and tissue chromium in Sprague-Dawley rats] J Zhejiang Univ Sci B. 2007; 5 (8): 323-30.
Downloads
Published
How to Cite
Issue
Section
License
The authors who publish their materials in this journal agree with the following terms:
- Authors reserve the right to authorship of their work and assign to the journal the right to first publish this work under the terms of the Creative Commons Attribution License, which allows other persons to freely distribute the published work with a mandatory reference to the authors of original work and the first publication of work in this journal
. - Authors have the right to make independent extra-exclusive work agreements in the form they are published by this journal (for example, posting work in an electronic repository of an institution or publishing as part of a monograph), provided that the link to the first publication of the work in this journal is maintained.
Journal policy allows and encourages publication of manuscripts on the Internet (for example, in institutions repositories or on personal websites), both before the publication of this manuscript and during its editorial review, as it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the citation of the published work (see The Effect of Open Access).
